New ABPI code provides more information for patients

doi:10.1136/bmj.331.7529.1409

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Richard Barker, director general (rley@abpi.org.uk)

Association of the British Pharmaceutical Industry (ABPI), London SW1A 2DY

Editor—Shaw et al highlight the benefits that will result if the pharmaceutical industry is enabled to communicate better with those who are its ultimate customers—patients.1

The revised ABPI (Association of the British Pharmaceutical Industry) code addresses in more detail the provision of information to the public. As for the current code, information must be factual and presented …